// App-Quantinova.ai

338 : Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients with Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

Researchers

Presenter

  • Tycel J. Phillips

Principal Investigators

  • Paolo Corradini

  • Ronit Gurion

  • Caterina Patti

  • Monica Tani

  • Abraham Avigdor

  • Wojciech Jurczak

  • Amitkumar Mehta

  • Pier Luigi Zinzani

  • Izidore S. Lossos

  • Catherine Thieblemont

  • Fred Zheng

  • Erica Rappold

  • Wanying Zhao

  • Peter Johnson

Medical Centers

  • Comprehensive Cancer Center, University of Michigan, Grass Lake, MI

  • Division of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy

  • Department of Hematology, Rabin Medical Center & Tel Aviv University, Tel Aviv, Israel

  • Department of Hematology,Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello,Palermo,Italy

  • Azienda Unità Sanitaria Locale della Romagna, Ospedale di Ravenna, Ravenna, Italy

  • Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • The Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw,Warsaw,Poland

  • University of Alabama at Birmingham School of Medicine, Birmingham, AL

  • Institute of Hematology, University of Bologna, Bologna, Italy

  • Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL

  • APHP, Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris Diderot, Paris, France

  • Incyte Corporation, Wilmington, DE

  • Cancer Research UK Oncology Unit, Southampton General Hospital, Southampton, United Kingdom

Locations

  • United States

  • Italy

  • Israel

  • Poland

  • France

  • United Kingdom

Companies

  • Incyte Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mucosa-associated lymphoid tissue lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • NCT03144674

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved